The purpose of this acquisition is to provide field center support services in the oakland, CA area to maximizeuse of data and samples amassed in cardia over more than 30 years to address new…
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N92018D00004
- Awardee
-
Kaiser Foundation Hospitals UEI P1RTMASB37B5
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $5,673,691 obligated
Award facts
- Opportunity
-
- HHSN26818HV00014R Solicitation number
- CARDIA Oakland Field Center Solicitation Award Notice · Posted Jun 26, 2017
- Combined order value
- $5,673,691 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 68% used
- $8,397,319.00
- Maximum order
- $8,397,319.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541713 Research and Development in Nanotechnology
- Set-aside
- No set-aside
- Competition
- 1 offer Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Walsh-Healey Public Contracts Act FAR subpart 22.6
Award details come from SAM.gov/FPDS.
About this IDV
The National Heart, Lung, and Blood Institute (NHLBI) awarded a single-award Indefinite Delivery Contract to Kaiser Foundation Hospitals (Kaiser Permanente) valued at $8.4 million with a period of performance from July 1, 2018 through June 30, 2024. The primary objective is to provide field center support services in the Oakland, California area to support the Coronary Artery Risk Development in Young Adults (CARDIA) study, a longitudinal epidemiological research initiative spanning more than 30 years. The contract encompasses three operational goals: (1) conducting continued cohort follow-up and data collection on clinical cardiovascular disease events; (2) fostering ongoing scientific collaborations; and (3) conducting limited clinical examinations of CARDIA participants to serve as a platform for ancillary study examination components. The scientific objectives focus on enhancing statistical power for analyzing predictors of clinical events, studying the progression of risk factors from subclinical to clinical cardiovascular disease, and identifying new risk factors or factor interactions that inform disease pathophysiology.
Under this IDV, Kaiser Permanente has been issued multiple delivery orders on a cost-no-fee basis. The first delivery order (Task Area A) was awarded June 20, 2018 for the period July 1, 2018 through June 30, 2019, valued at $3.9 million, with an option period extending through June 30, 2023. A second delivery order (Task Area B) was awarded November 14, 2019 for the period November 14, 2019 through October 31, 2021 (with no-cost extension through March 31, 2023), valued at $1.7 million. As an integrated healthcare system with extensive patient data resources and research infrastructure, Kaiser Permanente leverages its comprehensive electronic health records database and clinical capabilities to deliver cohort management, longitudinal data collection, participant clinical examination services, and epidemiological analysis in support of this critical cardiovascular disease research initiative.
Description
The purpose of this acquisition is to provide field center support services in the oakland, CA area to maximizeuse of data and samples amassed in cardia over more than 30 years to address new questions about thedevelopment and progression of clinical cardiovascular disease and related conditions. The scientific objectivesare to (1) enhancestatistical power to perform analyses of predictors of clinical events; (2) study the progression ofrisk factors tosubclinical to clinical CVD; and (3) identify new risk factors or interactions among factors that informdisease pathophysiology. The operational goals are to (1) conduct continued cohort follow-up and data collection onclinicalevents; (2) continue to foster scientific collaborations; and (3) conduct of a limited clinical examination of thecardia participants as a platform for ancillary study examination components.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Cardia oakland FC - task area B period of performance 11/14/2019 - 10/31/2021 | National Heart Lung and Blood Institute (NIH) | $1,730,913 | |
| Cardia oakland FC - task area aperiod of performance: 07/01/2018 - 06/30/2019 | National Heart Lung and Blood Institute (NIH) | $3,942,778 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N92018D00004?
75N92018D00004 was awarded to Kaiser Foundation Hospitals by National Heart Lung and Blood Institute (National Institutes of Health) on July 1, 2018.
How much is contract 75N92018D00004 worth?
Orders under 75N92018D00004 have obligated $5,673,691. 75N92018D00004's own ceiling is $8,397,319. A single order can be worth up to $8,397,319.
How many orders have been placed under contract 75N92018D00004?
2 orders have been placed under 75N92018D00004, the latest on November 14, 2019.
Who can order from contract 75N92018D00004?
75N92018D00004 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N92018D00004 competed?
The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV